Therapeutic Hemoglobin Levels after Gene Transfer in β-Thalassemia Mice and in Hematopoietic Cells of β-Thalassemia and Sickle Cells Disease Patients-Reference-Cited by-同舟云学术

Therapeutic Hemoglobin Levels after Gene Transfer in β-Thalassemia Mice and in Hematopoietic Cells of β-Thalassemia and Sickle Cells Disease Patients

Published:2012-03-27 Issue:3 Volume:7 Page:e32345
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Breda Laura,Casu Carla,Gardenghi Sara,Bianchi Nicoletta,Cartegni Luca,Narla Mohandas,Yazdanbakhsh Karina,Musso Marco,Manwani Deepa,Little Jane,Gardner Lawrence B.,Kleinert Dorothy A.,Prus Eugenia,Fibach Eitan,Grady Robert W.,Giardina Patricia J.,Gambari Roberto,Rivella Stefano

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference34 articles.

1. Molecular Mechanism of ß Thalassemia; Bernard G. Forget;MH Steinberg,2001

2. Sickle cell anemia, a molecular disease.;L Pauling;Science,1949

3. Therapeutic options for patients with severe beta-thalassemia: the need for globin gene therapy.;M Sadelain;Hum Gene Ther,2007

4. Future alternative therapies for β-thalassemia.;S Rivella,2009

Cited by 84 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hematopoietic stem cell gene therapy improves outcomes in a clinically relevant mouse model of multiple sulfatase deficiency;Molecular Therapy;2024-08

2. Therapeutic Relevance of Inducing Autophagy in β-Thalassemia;Cells;2024-05-25

3. Hematopoietic stem cell gene therapy improves outcomes in a clinically relevant mouse model of Multiple Sulfatase Deficiency;2024-03-12

4. Optimizing lentiviral genomic integrations to cure beta-thalassemia: The least required for success?;Molecular Therapy - Methods & Clinical Development;2024-03

5. Cellular and animal models for the investigation of β-thalassemia;Blood Cells, Molecules, and Diseases;2024-01